Victoria Llado Canellas

USA CSO And Strategy at Laminar Pharma

Victoria Llado has a diverse range of work experience in the field of biomedical research. Victoria started their career as a PhD student at the Universitat de les Illes Balears, where they focused on studying the effectiveness and mechanism of action of an anti-tumor molecule. After completing their PhD, they worked as a postdoctoral fellow at the same university, continuing their research on different molecules for the treatment of glioma, a type of brain cancer. Victoria also gained experience in lipidomic techniques and laboratory and financial management during this time.

In 2011, Victoria joined the Sanford-Burnham Medical Research Institute as a postdoctoral fellow, where they studied the role of atypical C-kinase proteins in intestinal homeostasis and tumorigenesis. Victoria then moved to the Massachusetts General Hospital/Harvard Medical School for another postdoctoral fellowship, focusing on the effect of chitinases on inflammatory bowel disease and colon cancer.

Victoria also worked as a biologist at Labo'Life, where they were involved in research and innovation. Victoria later joined the Fundación Marathon as a senior scientist, participating in the development of new anti-cancer drugs and studying the mechanism of action of a new drug in pancreatic cancer.

In 2015, Victoria returned to the Universitat de les Illes Balears as a research collaborator, while also taking on the role of Chief Scientific Officer at Laminar Pharma. In their role at Laminar Pharma, they led research in drug discovery and pre-clinical studies, established research collaborations, coordinated clinical studies, raised funds for the company, and represented the company at scientific and investment events. This position was supported by a Torres Quevedo Fellowship from the Ministry of Science and Innovation.

Throughout their career, Victoria has demonstrated a strong background in cancer research, drug development, and scientific leadership.

Victoria Llado's education history begins in 1998, when they enrolled at the Universitat de les Illes Balears to pursue a Licenciatura en Biología. Victoria completed their undergraduate degree in this field in 2004.

Subsequently, Victoria continued their studies at the same university and pursued a Licenciatura en Bioquímica from 2003 to 2005. The field of study for this degree is not specified.

From 2004 to 2009, Victoria furthered their education at the Universitat de les Illes Balears and obtained a Doctorado en Ciencias in Biology/General Biological Sciences. This signifies that they have achieved a doctoral level of expertise in the field of Biology.

No additional information is provided to expand upon Victoria Llado's education history beyond the given chronological details.

Links

Previous companies

Massachusetts General Hospital logo

Timeline

  • USA CSO And Strategy

    February, 2021 - present

  • Chief Scientific Officer (sponsored by a Torres Quevedo Fellowship)

    December, 2018

A panel showing how The Org can help with contacting the right person.